4 Analysts Assess Haemonetics: What You Need To Know
4 Analysts Assess Haemonetics: What You Need To Know
4 位分析師評估血液學：你需要知道的
During the last three months, 4 analysts shared their evaluations of Haemonetics (NYSE:HAE), revealing diverse outlooks from bullish to bearish.
在過去的三個月中，4位分析師分享了他們對Haemonetics（紐約證券交易所代碼：HAE）的評估，揭示了從看漲到看跌的不同前景。
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
下表簡要概述了分析師最近的評級，提供了對過去30天情緒變化的見解，並與前幾個月進行了比較以獲得整體視角。
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $110.5, a high estimate of $125.00, and a low estimate of $105.00. Witnessing a positive shift, the current average has risen by 2.0% from the previous average price target of $108.33.
分析師通過對12個月目標股價的評估提供了更深入的見解，顯示平均目標價爲110.5美元，最高估計爲125.00美元，低估值爲105.00美元。當前的平均價格從之前的平均目標價108.33美元上漲了2.0％，出現了積極的變化。
Decoding Analyst Ratings: A Detailed...
解碼分析師...
登入免費觀看全文
登入/註冊